Skip to main content

Please wait ...

Andrew Penn, RN, MS, NP, CNS, APRN-BC

Andrew Penn RN, MS, NP, CNS, APRN-BC, UC San Francisco trained psychiatric nurse practitioner. Associate clinical professor in the UCSF School of Nursing, practicing at the San Francisco VA. He has worked as study therapist on a MDMA-assisted therapy protocol for PTSD.


Speaker Disclosures:
Financial: Andrew Penn has employment relationships with the UCSF School of Nursing and with the San Francisco Veterans Administration Hospital. He is a study therapist for trials sponsored by the Experience Multidisciplinary Association for Psychedelic Studies and the Usona Institute. Andrew Penn is a researcher for the Psychedelics and Wellness Study (PAWS) at Texas Tech University and Psilocybin Assisted Therapy for Bipolar Depression. He receives a speaking honorarium and recording royalties from PESI, Inc. He has no relevant financial relationships with ineligible organizations.
Non-financial: Andrew Penn is the co-founder of the Organization of Psychedelic and Entheogenic Nurses. He is the founder of the UCSF School of Nursing Psychedelic Therapy Journal Club. Andrew Penn is a member of the American Psychiatric Nurses Association.

The Use of Mind-Altering Substances: MDMA, Psilocybin, and Marijuana for Treating PTSD and other Mental Distress

Michael Mithoefer, MD |  Rick Doblin, PhD |  Phil Wolfson, MD |  Sue Carter, PhD |  Robin Carhart-Harris, PhD |  Andrew Penn, RN, MS, NP, CNS, APRN-BC |  Richard C. Schwartz, PhD |  Anne Wagner, PhD, C Psych |  ....
3 Hours 59 Minutes
May 18, 2021
Product Code:
Media Type:
Digital Seminar
$89.99 - 2023 Sweet Sale Standard - $179.99

Showing 1 to 2 of 2 entries